Advertisement
ATYR vs IPHA
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ATYR is a Hold and IPHA is a Hold.
ATYR in -14.67% downward trend, falling for three consecutive days on October 14, 2026
Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where ATYR declined for three days, in 272 of 319 cases, the price declined further within the following month. The odds of a continued downward trend are 85%.
Technical Analysis (Indicators)
Bearish Trend Analysis
The Aroon Indicator for ATYR entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.
ATYR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 11 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 56 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.350) is normal, around the industry mean (2.835). P/E Ratio (-0.276) is within average values for comparable stocks, (-0.607). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.264) among similar stocks. P/S Ratio (196.078) is also within normal values, averaging (438.009).
The Tickeron Price Growth Rating for this company is 97 (best 1 - 100 worst), indicating slightly worse than average price growth. ATYR’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 99 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ATYR’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
IPHA in downward trend: 10-day moving average crossed below 50-day moving average on September 17, 2026
The 10-day moving average for IPHA crossed bearishly below the 50-day moving average on September 17, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 18 of 20 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
IPHA moved below its 50-day moving average on September 17, 2026 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where IPHA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for IPHA entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where IPHA's RSI Oscillator exited the oversold zone, 23 of 24 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 19 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a +1.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where IPHA advanced for three days, in 148 of 202 cases, the price rose further within the following month. The odds of a continued upward trend are 73%.
IPHA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 17 (best 1 - 100 worst) indicates that the company is slightly undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-3.943) is normal, around the industry mean (2.835). P/E Ratio (-2.804) is within average values for comparable stocks, (-0.607). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (135.264) among similar stocks. P/S Ratio (55.556) is also within normal values, averaging (438.009).
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 81 (best 1 - 100 worst), indicating slightly worse than average price growth. IPHA’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IPHA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock worse than average.
ATYR | IPHA | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 50 | 50 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 56 Fair valued | 17 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 99 | 98 | |
PRICE GROWTH RATING 1..100 | 97 | 81 | |
P/E GROWTH RATING 1..100 | 11 | 26 | |
SEASONALITY SCORE 1..100 | 33 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IPHA's Valuation (17) in the null industry is somewhat better than the same rating for ATYR (56). This means that IPHA’s stock grew somewhat faster than ATYR’s over the last 12 months.
IPHA's Profit vs Risk Rating (100) in the null industry is in the same range as ATYR (100). This means that IPHA’s stock grew similarly to ATYR’s over the last 12 months.
IPHA's SMR Rating (98) in the null industry is in the same range as ATYR (99). This means that IPHA’s stock grew similarly to ATYR’s over the last 12 months.
IPHA's Price Growth Rating (81) in the null industry is in the same range as ATYR (97). This means that IPHA’s stock grew similarly to ATYR’s over the last 12 months.
ATYR's P/E Growth Rating (11) in the null industry is in the same range as IPHA (26). This means that ATYR’s stock grew similarly to IPHA’s over the last 12 months.
| ATYR | IPHA | |
|---|---|---|
| RSI ODDS (%) | 3 days ago 77% | 3 days ago 90% |
| Stochastic ODDS (%) | N/A | 3 days ago 84% |
| Momentum ODDS (%) | N/A | N/A |
| MACD ODDS (%) | N/A | N/A |
| TrendWeek ODDS (%) | 3 days ago 86% | 3 days ago 84% |
| TrendMonth ODDS (%) | 3 days ago 85% | 3 days ago 84% |
| Advances ODDS (%) | N/A | 13 days ago 73% |
| Declines ODDS (%) | 5 days ago 85% | 5 days ago 85% |
| BollingerBands ODDS (%) | 3 days ago 84% | 3 days ago 85% |
| Aroon ODDS (%) | 3 days ago 85% | 3 days ago 79% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ATYR’s FA Score shows that 1 FA rating(s) are green while IPHA’s FA Score has 2 green FA rating(s).
- ATYR’s FA Score: 1 green, 4 red.
- IPHA’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ATYR’s TA Score shows that 2 TA indicator(s) are bullish while IPHA’s TA Score has 4 bullish TA indicator(s).
- ATYR’s TA Score: 2 bullish, 2 bearish.
- IPHA’s TA Score: 4 bullish, 4 bearish.
Price Growth
ATYR (@Biotechnology) experienced а -29.33% price change this week, while IPHA (@Biotechnology) price change was -11.73% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -10.78%. For the same industry, the average monthly price growth was -18.33%, and the average quarterly price growth was -21.56%.
Reported Earning Dates
ATYR is expected to report earnings on Nov 05, 2026.
IPHA is expected to report earnings on Nov 05, 2026.
Industries' Descriptions
@Biotechnology (-10.78% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| UTWO | 47.58 | 0.05 | +0.12% |
| US Treasury 2 Year Note ETF (UTWO) | |||
| ACWV | 127.37 | 0.13 | +0.10% |
| iShares MSCI Global Min Vol Factor ETF (ACWV) | |||
| MYCO | 23.26 | -0.02 | -0.09% |
| State Street My2035 Corporate Bond ETF (MYCO) | |||
| TEK | 36.52 | -1.37 | -3.60% |
| iShares Technology Opportunities Active ETF | |||
| FRTY | 21.38 | -0.94 | -4.21% |
| Alger Mid Cap 40 ETF (FRTY) | |||
ATYR and
Correlation & Price change
A.I.dvisor indicates that over the last year, ATYR has been loosely correlated with AMLX. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ATYR jumps, then AMLX could also see price increases.
| Ticker / NAME | Correlation To ATYR | 1D Price Change % | ||
|---|---|---|---|---|
| ATYR | 100% | -5.33% | ||
| AMLX - ATYR | 39% Loosely correlated | -4.74% | ||
| IDYA - ATYR | 39% Loosely correlated | -2.95% | ||
| NTLA - ATYR | 38% Loosely correlated | +0.71% | ||
| IPHA - ATYR | 37% Loosely correlated | -3.38% | ||
| OCUL - ATYR | 35% Loosely correlated | -6.91% | ||
More | ||||
IPHA and
Correlation & Price change
A.I.dvisor indicates that over the last year, IPHA has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if IPHA jumps, then MDGL could also see price increases.
| Ticker / NAME | Correlation To IPHA | 1D Price Change % | ||
|---|---|---|---|---|
| IPHA | 100% | -3.38% | ||
| MDGL - IPHA | 43% Loosely correlated | -2.19% | ||
| APLM - IPHA | 36% Loosely correlated | +4.06% | ||
| ATYR - IPHA | 35% Loosely correlated | -5.33% | ||
| FENC - IPHA | 34% Loosely correlated | -3.57% | ||
| CCXI - IPHA | 34% Loosely correlated | -6.08% | ||
More | ||||